See also: Mannkind: Analysts' Upgrades, Downgrades

Editor's Note: Green and red arrows refer to intraday stock price movement.

NEW YORK ( TheStreet) -- STOCK COMMENTS / EPS CHANGES

Analog Devices ( ADI) numbers upped at UBS. ADI estimates were boosted through 2012, UBS said. Company is seeing healthy underlying demand. Neutral rating and new $40 price target.

Adtran ( ADTN) estimates, target boosted at Goldman. Shares of ADTN now seen reaching $39. Estimates also upped, to match the company's new guidance. Neutral rating.

Amphenol ( APH) estimates, target raised at UBS. Shares of APH now seen reaching $57, according to UBS. Estimates also increased, to match the company's new guidance. Neutral rating.

eBay ( EBAY) price target higher at Credit Suisse to $34 from $32 after solid 4Q10 results. Healthy revenue growth at PayPal, augmented operating leverage, and progress at Marketplace, Credit Suisse said. Maintain Outperform rating.

eBay ( EBAY) target, estimates boosted at Barclays. EBAY price target increased to $33 from $29. Strong 4Q10 earnings driven by improvements in payments margins, Barclays said. 2011 EPS estimate lifted to $1.95 from $1.85. Maintain Equal Weight rating.

eBay ( EBAY) estimates, target boosted at UBS. Shares of EBAY now seen reaching $35. Estimates also upped, to match the company's new guidance. Buy rating.

Esterline ( ESL) estimates, target increased at UBS through 2012, UBS said. Company's margins are improving. Neutral rating and new $72 price target.

F5 Networks ( FFIV) numbers increased at Goldman. FFIV estimates were raised through 2013, Goldman Sachs said. Company is seeing better margins and taxes. Sell rating and new $90 price target.

Goldman Sachs ( GS) estimate cut at Barclays. GS 2011 and 2012 EPS estimates lowered to $14.40 and $16.10, respectively. Weak earnings driven by slow December, Barclays said. Maintain Equal Weight rating and $175 price target.

Goldman Sachs ( GS) target raised at FBR to $190. Company still delivered solid ROE, despite lower client activity. Outperform rating. Human Genome Sciences ( HGSI) numbers lowered at Piper. Shares of HGSI now seen reaching $33. Estimates also cut, as Benlysta might face a softer launch. Overweight rating.

Linear Technology ( LLTC) numbers raised at UBS. Shares of LLTC now seen reaching $34, according to UBS. Estimates also increased, as bookings appear to be bottoming. Neutral rating.

If you liked this article you might like

S&P 500 and Dow Score Records With Wall Street Upbeat Ahead of Fed

Nvidia Inspires Chipmaker Gains but Rest of Tech Gets Left Behind

S&P 500 and Dow on Track for Records With Markets in Good Mood Ahead of Fed

These Are the 27 Companies You Must Watch Ahead of Apple's Big Launch Event

Stunningly Out of Kilter; FANG May Rise -- Jim Cramer's Top Thoughts